4-Chloro-3-iodo-1H-pyrazolo[4,3-c]pyridine, 95.0%, 250mg

4,4,5,5-Tetramethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborolane, 95.0%, 1g

Ethyl 4-amino-6-chloropyridine-3-carboxylate, 95.0%, 10g

Ethyl 1-isopropyl-4-nitro-1h-pyrazole-3-carboxylate, 97%, 2.5g

4-methyl-6-piperazin-1-ylpyrimidine, 95.0%, 1g

5-(4-Bromophenyl)-2H-pyrazol-3-ylamine, 97.0%, 25g

(9H-Fluoren-9-yl)methyl (3-(methylamino)propyl)carbamate hydrochloride, 95%, 1g

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 0.50 µm, 1 Piece(s)

4-[(5-Bromopyrimidin-2-yl)oxy]aniline, 97.0%, 1g

1-(3-Fluoro-2-nitrophenyl)piperazine hydrochloride, 95.0%, 1g

3-(3-Aminopropyl)-5-(1h-indol-3-yl)pyrazin-2-amine, 98%, 500mg

3-Methoxy-2-methylpyridin-4-amine, 97%, 100mg

N-[4-[(4-propan-2-yloxyphenyl)methyl]phenyl]-4,5-dihydro-1H-imidazol-2-amine, 97%, 50mg